Tiziana Life Sciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Gross Profit | -146 | -88 | -88 |
EBITDA | -12,182 | -5,544 | -5,544 |
EBIT | -12,328 | -5,632 | -5,632 |
Net Income | -12,799 | -5,632 | -5,632 |
Free Cash Flow | -6,039 | -6,829 | -6,829 |
Cash | 4,010 | 7,251 | 7,251 |
Basic Shares | 59,467 | 58,413 | 58,413 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -234 | -51 | ||
EBITDA | -18,179 | -16,616 | -21,659 | -18,852 |
EBIT | -18,413 | -16,740 | -21,781 | -18,915 |
Net Income | -18,431 | -11,863 | -22,361 | -18,923 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,868 | -1,234 | -12,422 | -15,990 |
Cash | 4,010 | 3,724 | 1,183 | 18,122 |
Basic Shares | 59,141 | 53,336 | 50,763 | 50,763 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-03-31 | -$0.07 |
2024-09-30 | -$0.05 |
2022-09-30 | -$0.06 |